Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Create a wealth building plan for beginners that sets the foundation for financial success. Start your journey towards wealth today!
20,287 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Mark Cuban envisions AI enabling workers to finish earlier without a pay cut, a bold bet that could reshape budgets, ...
Delaware introduces a dedicated licensing regime for stablecoin issuers, placing them under the State Bank Commission...
The White House rejected Elon Musk’s public offer to fund TSA salaries during the budget stalemate, setting off a fre...
Geopolitics just accelerated volatility in energy markets. The rejection of a ceasefire proposal by iran has traders ...
Unity Software’s latest guidance sparked a sharp rally, underscoring how Vector AI could redefine monetization in int...
In a high-stakes Senate hearing, Treasury Secretary Scott Bessent denies a looming $14 billion windfall for Iran from...
A war in the Middle East can push energy prices higher and disrupt global supply chains. This unintended consequence ...
Qualcomm is trading at a discount to peers while building a strong AI silicon footprint. With a June Investor Day and...
Los Angeles-based luxury real estate brokerage Resident is expanding into Napa Valley, signaling a broader push into ...
A clear, practical look at Expedia's Q1 2026 earnings, what drove results, and what to watch next. Learn the segments...
Markets wobbled as President Trump labeled Iran’s ceasefire reply 'TOTALLY UNACCEPTABLE,' fueling a risk-off mood ami...